VEGFA and age-related macular degeneration: However, treatment using intravitreal anti-vascular endothelial growth factor (anti-VEGF) for exudative AMD can improve visual prognosis, and many randomized clinical trials have reported the favorable efficacy of anti-VEGF for exudative AMD [1,2,3,4,5,6].